Biocartis Group NV (XBRU:BCART) FFO

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

XBRU:BCART Biocartis Group NV XBRU:BCART
14 GF Score
Price €0.29
View Full Analysis

What is Biocartis Group NV FFO?

FFO (Funds from operations) only applies to REITs.

XBRU:BCART
14GF Score
Biocartis Group NV XBRU:BCART
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Biocartis Group NV Business Description

Address Generaal de Wittelaan 11 B, Mechelen, BEL, 2800
Biocartis Group NV is a commercial-stage molecular diagnostics company. It provides diagnostic solutions aimed at improving clinical practice for patients, clinicians, payers, and the industry. The firm has developed an Meet Idylla molecular diagnostic system for oncology and infectious disease segments.
14GF Score

Get the complete analysis for XBRU:BCART

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.29
Price